Home » Advocacy » Federal Government Relations

Federal Government Relations

Therapeutic Discovery Project Defending America's Competitiveness in Biotechnology
April 9, 2012

Capital formation challenges in the industry have forced many biotech companies to halt...

Therapeutic Discovery Project Helps Scientists Working To Cure Cancer
April 9, 2012

BIO believes that the level of support provided by the TDP simply cannot meet the needs of the...

Therapeutic Discovery Project Is Working to Create & Protect American Jobs
April 9, 2012

The biotech industry is a thriving sector employing 1.3 million Americans in high quality,...

Developing Policies that Foster Innovation
March 28, 2012

Acorda Therapeutics' Ron Cohen presented testimony on the importance of federal policies...

More Articles →

Letters, Testimony & Comments

BIO's Testimony to the House Appropriations, Labor HHS Subcommittee on the President's FY 2013 Budget Request for the National Institutes of Health (NIH)
March 20 2012
Good morning Chairman Rehberg, Ranking Member DeLauro, Members of the Committee, ladies, and gentlemen. I am Scott Koenig, President and...
BIO Supports the JOBS Act (H.R. 3606)
March 16 2012
Dear Majority Leader Reid and Minority Leader McConnell: On behalf of the Biotechnology Industry Organization (BIO) and its more than 1...
Spurring Job Growth Through Capital Formation While Protecting Investors
March 6 2012
William D. Waddill, Senior Vice President and Chief Financial Officer OncoMed Pharmaceuticals highlights the importance of capital...
BIO Written Testimony: Spurring Job Growth Through Capital Formation While Protecting Investors
December 1 2011
On December 1, BIO submitted written testimony to the Senate Committee on Banking, Housing, and Urban Affairs on the importance of...
Testimony in Support of USDA Research
July 28 2011
The Biotechnology Industry Organization (BIO) is the world's largest biotechnology organization, providing advocacy, business...
More Letters, Testimony & Comments →

Press Releases

BIO Submits Comments on FDA Draft Guidances on Biosimilars
April 17 2012
Washington, D.C. (April 17, 2012) – The Biotechnology Industry Organization (BIO) submitted comments yesterday...
BIO Applauds Congress for Passage of the Jumpstart Our Business Startups (JOBS) Act
March 27 2012
The Biotechnology Industry Organization (BIO) praises the House and Senate for passage of H.R. 3606, the Jumpstart...
Biotech Leader Provides Testimony at Congressional Hearing on ‘Spurring Job Growth through Capital Formation While Protecting Investors’
March 6 2012
Today, the Senate Committee on Banking, Housing, and Urban Affairs held a hearing on “Spurring Job Growth...
TREAT Act Offers Renewed Hope for Patients
February 15 2012
Washington, DC (February 15, 2012) – Today, the Biotechnology Industry Organization (BIO) praised Sen. Kay...
Biotechnology Can Provide Foundation for A U.S. Economy “Built To Last”
January 25 2012
BIO Calls On the Administration and Congress to Embrace Proposals to Unleash the Promise of Biotechnology...
More Press Releases →